Latest news
Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $277.92, Implies 7% Upside - TradingViewTradingView · Thu, 06 Aug 2026 20:26:20 GMTCharles River Associates Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 16:03:59 GMTCharles River Laboratories International Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 11:04:15 GMTStock Indices Fall from Early Highs and Settle Mixed - TradingViewTradingView · Wed, 05 Aug 2026 20:34:28 GMTCharles River Says Biotech Demand Is Back — Bookings Hit Four-Year High - TradingViewTradingView · Wed, 05 Aug 2026 18:03:45 GMTCRL: Raised guidance after strong Q2 results, margin gains, and robust DSA bookings - TradingViewTradingView · Wed, 05 Aug 2026 16:19:08 GMTStocks Supported by Stellar Earnings - TradingViewTradingView · Wed, 05 Aug 2026 15:14:55 GMTCHARLES RIVER LABORATORIES INTERNATIONAL, INC. 2026: Revenue $1B, EPS ($0.03) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 13:31:10 GMT